Press Room
  Date Title View
Jan 11, 2016
FOSTER CITY, Calif., Jan. 11, 2016 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced its preliminary 2015 revenue results, and that it has achieved its revenue expectations for 2015. For 2015, the Company expects 2015 sales revenues of between $157 and $158 million, which are at the high end of the guidance o...
PDF
Dec 21, 2015
FOSTER CITY, Calif., Dec. 21, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced plans to pursue development and registration of SGX942 in the Greater China market, for the treatment of oral mucositis. SGX942 is being developed by Soligenix, Inc. (OTCQB: SNGX), which recently reported positive preliminary results fro...
PDF
Nov 17, 2015
FOSTER CITY, Calif., Nov. 17, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at the 27th Annual Piper Jaffray Healthcare Conference at 10:30 am ET on Wednesday, December 2, 2015, at the New York Palace Hotel...
PDF
Nov 9, 2015
FOSTER CITY, Calif., Nov. 9, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended September 30, 2015. Revenues: In the third quarter of 2015, SciClone reported revenues of $42.9 million, compared to $34.3 million for the same period in 2014.  GAAP Diluted EPS: I...
PDF
Nov 3, 2015
FOSTER CITY, Calif., Nov. 3, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will participate in a panel discussion at the Boston Biotech Conferences (BBC) NY/NJ CEO conference on November 12th, at the Apella in New York City. The conference will foc...
PDF
Oct 26, 2015
FOSTER CITY, Calif., Oct. 26, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2015 on Monday, November 9, 2015. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call wil...
PDF
Sep 30, 2015
FOSTER CITY, Calif., Sept. 30, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and business update at the 2015 Aegis Capital Growth Conference at 11:25 am PT on Friday, October 9, 2015, at The Encore at Wynn Las Vegas.   T...
PDF
Aug 27, 2015
FOSTER CITY, Calif., Aug. 27, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at two investor conferences on September 10, 2015, in New York City. 22nd Annual NewsMakers in the Biotech Industry: pr...
PDF
Aug 10, 2015
FOSTER CITY, Calif., Aug. 10, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended June 30, 2015.   Revenues: In the second quarter 2015, SciClone reported revenues of $37.9 million, compared to $32.5 million for the same period in 2014. GAAP Diluted EPS:...
PDF
Jul 23, 2015
FOSTER CITY, Calif., July 23, 2015 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the second quarter 2015 on Monday, August 10, 2015. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call wil...
PDF
FirstPrevious
3
...
NextLast